Send us a Text Message.

In this episode, we explore the impact of age-related macular degeneration (AMD) on vision and overall quality of life. Dr. Armstrong and Corbin Bruton are joined by Drs. Kai Chan and Andrew Dick, founders of Cirrus Therapeutics, to discuss the complexities of AMD, its risk factors, and current treatment options. They delve into a groundbreaking novel therapy developed by Cirrus Therapeutics that uses genetic instructions to produce the protein IRAK-M, offering new hope for protecting against retinal degeneration. Tune in to learn more about AMD, its prevention, the promising advancements in ocular immunology that aim to restore vision for millions, and the complex interactions between vision health and… aging well.

Related Articles:

Researchers unveil pioneering approach to combat age-related vision loss

Jian Liu et al. (2024). Replenishing IRAK-M expression in retinal pigment epithelium attenuates outer retinal degeneration. Science Translational Medicine, 16: eadi4125. DOI:10.1126/scitranslmed.adi4125

Support the Show.

Have questions you want answered and topics you want discussed on the Aging Well Podcast? Send us an email at agingwell.podcast@gmail.com or record your question for us to use in an upcoming episode:
https://www.speakpipe.com/AgingWellPodcast